Por favor, use este identificador para citar o enlazar este ítem:
https://doi.org/10.1016/j.mayocp.2020.05.046
Twittear
Registro completo de metadatos
Campo DC | Valor | Lengua/Idioma |
---|---|---|
dc.contributor.author | Rivera-Caravaca, José Miguel | - |
dc.contributor.author | Roldán Schilling, Vanessa | - |
dc.contributor.author | Vicente García, Vicente | - |
dc.contributor.author | Lip, Gregory YH | - |
dc.contributor.author | Marín Ortuño, Francisco | - |
dc.contributor.other | Facultades, Departamentos, Servicios y Escuelas::Departamentos de la UMU::Enfermería | - |
dc.date.accessioned | 2024-02-07T09:46:25Z | - |
dc.date.available | 2024-02-07T09:46:25Z | - |
dc.date.issued | 2020 | - |
dc.identifier.citation | Mayo Clinic Proceedings, Volume 95, Issue 11, November 2020, Pages 2360-2369 | es |
dc.identifier.issn | Print: 0025-6196 | - |
dc.identifier.uri | http://hdl.handle.net/10201/138842 | - |
dc.description | ©2020 Mayo Foundation for Medical Education and Research. This document is the Published version of a Published Work that appeared in final form in Mayo Clinic Proceedings. To access the final edited and published work see https://doi.org/10.1016/j.mayocp.2020.05.046 | - |
dc.description.abstract | Objective: To test the hypothesis that particulate matter with an aerodynamic diameter of less than 10 mm (PM10) and temperature are associated with an increased risk of adverse clinical outcomes in patients with atrial fibrillation (AF) taking vitamin K antagonists (VKAs). Patients and Methods: We included patients with AF whose condition was stable while taking VKAs (international normalized ratio, 2.0 to 3.0) for 6 months seen in a tertiary hospital (recruitment from May 1, 2007, to December 1, 2007). During a median follow-up of 6.5 years (interquartile range, 4.3 to 7.9 years), ischemic strokes, major bleeding, adverse cardiovascular events, and mortality were recorded. From 2007 to 2016, data on average temperature and PM10 were compared with clinical outcomes. Results: The study group included 1361 patients (663 [48.7%] male; median age, 76 years [interquartile range, 71 to 81 years]). High PM10 and low temperatures were associated with higher risk of major bleeding (adjusted hazard ratio [aHR], 1.44; 95% CI, 1.22 to 1.70 and aHR, 1.03; 95% CI, 1.01 to 1.05, respectively) and mortality (aHR, 1.50; 95% CI, 1.34 to 1.69 and aHR, 1.04; 95% CI, 1.02 to 1.06, respectively); PM10 was also associated with ischemic stroke and temperature with cardiovascular events. The relative risk (RR) for cardiovascular events and mortality increased in months in the lower quartile of temperature (RR, 1.12; 95% CI, 1.04 to 1.21 and RR, 1.41; 95% CI, 1.15 to 1.74, respectively). Comparing seasons, there were higher risks of cardiovascular events in spring, autumn, and winter than in summer, whereas the risk of mortality increased only in winter. Conclusion: In patients with AF taking VKAs, high PM10 and low temperature were associated with increased risk of ischemic stroke and cardiovascular events, respectively. Both factors increased major bleeding and mortality risks, which were higher during colder months and seasons. | es |
dc.format | application/pdf | es |
dc.format.extent | 10 | es |
dc.language | eng | es |
dc.publisher | Elsevier | - |
dc.relation | Instituto de Salud Carlos III (PI17/01375) y grupo CB16/11/00385 del CIBERCV | es |
dc.rights | info:eu-repo/semantics/embargoedAccess | es |
dc.subject.other | CDU::6 - Ciencias aplicadas::61 - Medicina | es |
dc.title | Particulate matter and temperature: increased risk of adverse clinical outcomes in patients with atrial fibrillation | es |
dc.type | info:eu-repo/semantics/article | es |
dc.embargo.terms | Si | - |
dc.identifier.doi | https://doi.org/10.1016/j.mayocp.2020.05.046 | - |
Aparece en las colecciones: | Artículos: Enfermería |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
Particulate Matter and Temperature.pdf | 561,67 kB | Adobe PDF | Visualizar/Abrir Solicitar una copia |
Los ítems de Digitum están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.